The process of determining the insulin sensitivity factor allows individuals with diabetes to estimate the decrease in blood glucose levels resulting from one unit of rapid-acting insulin. This factor, expressed as milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L) per unit of insulin, guides the adjustment of insulin doses to correct hyperglycemia. A common method for its estimation involves dividing a standardized figure, often 1700 or 1800 (depending on whether glucose is measured in mg/dL or mmol/L), by the total daily dose of insulin. For example, an individual taking 40 units of insulin daily might have an insulin sensitivity factor of 42.5 mg/dL per unit (1700/40) or 1.1 mmol/L per unit (1800/40 divided by 18). This suggests that one unit of insulin should lower their blood glucose by approximately 42.5 mg/dL or 1.1 mmol/L.
Precisely determining this factor is crucial for effective diabetes management, enabling individuals to proactively address elevated glucose levels and maintain tighter glycemic control. This proactive control can significantly reduce the risk of both acute complications, such as diabetic ketoacidosis, and long-term complications, including cardiovascular disease, nephropathy, and neuropathy. Historically, reliance on fixed insulin regimens often led to suboptimal blood glucose control; the introduction of individualized correction factors represents a significant advancement in diabetes care, facilitating personalized therapy and improved patient outcomes.
